R97.21

Billable

Rising PSA fol treatment for malignant neoplasm of prostate

Rising PSA following treatment for malignant neoplasm of prostate

Status

Billable / Specific

Block

R97-R97

Parent Code

R97.2

Coding Notes

Excludes 2

Conditions not included here, but the patient may have both

  • abnormal findings on antenatal screening of mother (O28.-)
  • certain conditions originating in the perinatal period (P04-P96)
  • signs and symptoms classified in the body system chapters
  • signs and symptoms of breast (N63, N64.5)

Also Known As / Clinical Terms

Frequently Asked Questions

What is ICD-10 code R97.21?

ICD-10-CM code R97.21 represents "Rising PSA following treatment for malignant neoplasm of prostate". It is a billable/specific code that can be used on a claim.

Is R97.21 a billable code?

Yes, R97.21 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is R97.21 in?

R97.21 is in Chapter 18: Symptoms, Signs and Abnormal Clinical and Laboratory Findings (codes R00-R99).

What are the UMLS CUIs for R97.21?

R97.21 is linked to 1 UMLS Concept Unique Identifier: C4269227. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.